| Total (N = 288) | Consultation group (N = 196) | Non-consultation group (N = 92) | Analysis | ||||
---|---|---|---|---|---|---|---|---|
 | N | (%) | N | (%) | N | (%) | X2 | P-value |
Diagnosis | Â | Â | Â | Â | Â | Â | Â | Â |
Organic, including symptomatic, mental disorders (F0) | 9 | (3.1) | 1 | (0.5) | 8 | (8.7) | Â | n.s |
Mental and behavioural disorders due to psychoactive substance use (F1) | 16 | (5.6) | 12 | (6.1) | 4 | (4.3) | Â | n.s |
Schizophrenia, schizotypal and delusional disorders (F2) | 59 | (20.5) | 51 | (26.0) | 8 | (8.7) | 11.5 | <0.01 |
Mood disorders (F3) | 89 | (30.9) | 59 | (30.1) | 30 | (32.6) | Â | n.s |
Neurotic, stress-related and somatofom disorders (F4) | 68 | (23.6) | 37 | (18.9) | 31 | (33.7) | 7.6 | <0.01 |
Disorders of adult personality and behaviour (F6) | 29 | (10.1) | 26 | (13.3) | 3 | (3.3) | 6.9 | <0.01 |
Disorders of psychological development (F8) | 8 | (2.8) | 5 | (2.6) | 3 | (3.3) | Â | n.s |
Others | 10 | (3.5) | 5 | (2.6) | 5 | (5.4) | Â | n.s |